Hypoxia due to shunts in pig lung treated with O2 and fluorocarbon-derived intravascular microbubbles

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 38, Issue 2, 2010, Pages 79-89

  Tyssebotn, Ingvald M ^a,b   Lundgren, Claes E G ^a   Olszowka, Albert J ^a   Bergoe, Guri W ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Athelectasis; Blood gases; Fluorocarbons; Lung pathology; Microbubbles; Oxygen therapy; Right to left pulmonary shunts; Ventilation perfusion ratio

Indexed keywords

ARTERIAL PRESSURES; ATHELECTASIS; DODECAFLUOROPENTANE; EMBOLIZATION; EXPERIMENTAL CONDITIONS; GLASS BEAD; INTRAVASCULAR; LUNG PATHOLOGY; MICROBUBBLES; MUSCLE TISSUES; OXYGEN SATURATION; OXYGEN TENSION; TISSUE OXYGENATION; TOXIC EFFECT; TOXICITY TESTING;

ANIMALS; BIOLOGICAL ORGANS; BLOOD; EMULSIFICATION; FLUOROCARBONS; GASES; OXYGENATION; OXYGENATORS; PATHOLOGY; RESPIRATORY THERAPY;

OXYGEN;

OXYGEN; PERFLUOROPENTANE;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; EMULSION; FEMALE; HEART RIGHT LEFT SHUNT; HYPOXIA; LUNG; LUNG GAS EXCHANGE; MALE; MICROBUBBLE; NONHUMAN; OXYGEN BREATHING; SHUNTING; TISSUE OXYGENATION; TRACHEA;

ANIMALS; ANOXIA; ARTERIOVENOUS SHUNT, SURGICAL; CARBON DIOXIDE; DISEASE MODELS, ANIMAL; FLUOROCARBONS; HYPERBARIC OXYGENATION; INJECTIONS, INTRAVENOUS; MICROBUBBLES; OXYGEN; RESPIRATION; SWINE;

ANIMALIA; SUIDAE;

EID: 77949449379     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731191003634679     Document Type: Article

References (14)

1. Lundgren, C.E.G., Bergoe, G., Tyssebotn, I.M. (2006). Intravascular fuorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artifcial Cells, Blood Substitutes, and Biotechnology, an International Journal 34:473-486.
2. Koch, J.C., Oprysko, P.R., Shuman, A.L., Jenkins, W.T., Brandt, G., Evans, S.M. (2002). Radiosensitization of hypo-xic tumor cells by dodecafuoropentane: a gas-phase per-fuorochemical emulsion. Cancer Research 62:3626-3629.
3. Burkard, M.E., Van Liew, H.D. (1994). Oxygen transport to tissue by persistent bubbles: Theory and simulations. J Appl Physiol 77:2874-2878.
4. Van Liew, H.D., Burkard, M.E. (1996). Relationship of oxygen content to PO2 for stabilized bubbles in the circulation: theory. J Appl Physiol 81:500-508.
5. Correas, J.M., Quay, S.D. (1996). EchoGenTM emulsion: A new ultrasound contrast agent based on phase shift colloids. Clinical Radiology 51(Suppl. 1):11-14.
6. Lopez-Ben, R., Robin, M.L., Weber, T.M., Smith, J.K., Needleman, L., Berland, L.L. (1999). Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perfenapent emulsion: preliminary study. J Ultrasound Med 18:109-116.
7. Quay, S. C. (1999) Composition comprising a fuorine containing surfactant and perfuoropentane for ultrasound. US patent No. 5,876,696.
8. Olszewski, R., Marciniak, W., Nowicki, A., Etienne, J., Karlowicz, P., Adamus, J. (1998). The improvement of endocardiographic assessment of left ventricle by the use of permafent and harmonic imaging. Polski Merkuriusz Lekarski 5:132-134
9. Walker, K.W., Pantely, G.A., Sahn, D.J. (1997). Ultrasound-mediated destruction of contrast agents. Effect of ultrasound intensity, exposure and frequency. Investigative Radiology 32:728-734
10. Eyal, F.G., Hachey, W.E., Curtet-Eval, N.L., Kellum, F.E., Alpan, G. (1996). Effect of modulators of hypoxic pulmonary vasoconstriction on the response to inhaled nitric oxide in a neonatal model of severe pulmonary atelectasis. Semin Perinatol 20:186-193
11. Serianni, R., Barash, J., Bentley, T., Sharma, Fontana, J.L., Via, D., Duhm, J., Bunger, R., Mongan, P.D. (2003). Porcine-specifc hemoglobin saturation measurements. J Appl Physiol 94:561-566.
12. Lundgren, C., Bergoe, G., Olszowka, A., Tyssebotn, I. (2005). Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fuorocarbon-derived intravascular micro-bubbles. Undersea and Hyperbaric Medicine 32:215-226.
13. Quay, S.C., Eisenfeld, A.J. (1997). Safety assessment of the use of perfenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies. Clinical Cardiology 20(Suppl. 1): I19-26.
14. Personal communication. (2005) From the then Marketing and Business Manager, Mr. Mark Low, at Sonus Pharmaceuticals, Inc.